Pia Campagna

Neuroscience & Genomics PhD Candidate


Hello!

I'm a final year PhD candidate at Monash University identifying genomic and prognostic biomarkers in multiple sclerosis.I'm very interested in digital health and DeSci as a Startmate Student Fellow (W21) and cofounder of HelpMate.



PhD Thesis

My thesis consists of 3 main studies:Genetic predictors of treatment response to disease-modifying therapies.The association between, and prognostic capacity of, DNA methylation for disease severity.Pregnancy-related changes in methylation and immunobiology in women with multiple sclerosis.



Publications

1. Campagna MP, Xavier A, Stankovich J, et al., Birth history is associated with whole-blood and T-cell methylation patterns in relapse onset multiple sclerosis, medRxiv, 2022 Mar, DOI: https://doi.org/10.1101/2022.03.24.222729172. Campagna MP, Xavier A, Lechner-Scott J, et al., Epigenome-wide association studies: current knowledge, strategies and recommendations, 2021 Dec, DOI: 10.1186/s13148-021-01200-83. Rath L, Campagna MP, Stankovich J, et al., Assessing Patient Preference: Preferred time and location of infusible therapies in Multiple Sclerosis and Neuroimmunological disorders. Internat Journal of MS Care 2020. DOI: 10.7224/1537-2073.2020-0754. Zhong M, van der Walt A, Campagna MP, et al. The Pharmacogenetics of Rituximab: Potential Implications for Anti-CD20 Therapies in Multiple Sclerosis. Neurotherapeutics: the Journal of the American Society for Experimental Neurotherapeutics. 2020 Oct;17(4):1768-1784. DOI: 10.1007/s13311-020-00950-2.





Leadership

I'm passionate about broadening the social and professional networks of Australian graduate students.I've held executive leadership positions on the CCS Graduate Research Student (CGRS) Committee, Students of Brain Research (SOBR) Network Committee, and Australian Computational Biology and Bioinformatics Student Society (COMBINE) committee.I've also previously mentored with the New York Academy of Sciences, Monash University Alumni to Student Mentoring Program, and BrainStem.





Presentations

2022 MS Australia Progress in Scientific Research Conference. Title: The impact of pregnancy on DNA methylation in relapse-onset multiple sclerosis. Speaker selected from abstract. Awarded Best Young Investigator Oral Presentation2022 MS Australia Progress in Scientific Research Conference. Title: Whole-blood methylation as a prognostic biomarker in multiple sclerosis. Flash presentation speaker selected from abstract2021 GeneMappers Conference. Title: Whole-blood methylation as a prognostic biomarker in multiple sclerosis. Lightning presentation speaker selected from abstract Awarded 1st Place for Best Student Lightning Presentation2021 Australian Society of Medical Research (ASMR) Victorian Symposium. Title: Whole-blood methylation as a prognostic biomarker in multiple sclerosis. Speaker selected from abstract Awarded 1st Place for Best Oral Presentation2021 International Society for Computational Biology Great Lakes Bioinformatics Conference. Whole-blood methylation as a prognostic biomarker in multiple sclerosis. Platform speaker selected from abstract2020 Monash University Central Clinical School Graduate Research Symposium. Using DNA methylation to predict disease severity in multiple sclerosis. Speaker selected from abstract. Awarded 2nd Place for Best Oral Presentation & Committee Choice for Best Oral Presentation2020 Monash University Neuroscience in a Flash. Using DNA methylation to predict disease severity in multiple sclerosis. Speaker selected from abstract




© Pia Campagna. All rights reserved.